Mosquitoes are deadly efficient disease transmitters. Research conducted
at Michigan State University, however, demonstrates that they also can
be part of the solution for diseases such as malaria. A study in the current issue of
Science shows that the transmission of malaria via mosquitoes to humans can be interrupted by using a strain of the bacteria
Wolbachia in the insects. In a sense,
Wolbachia
would act as a vaccine of sorts for mosquitoes that would protect them
from malaria parasites. Treating mosquitoes would prevent them from
transmitting malaria to humans, a disease that in 2010 affected 219
million people and caused an estimated 660,000 deaths.
"
Wolbachia-based malaria control strategy has been discussed
for the last two decades," said Zhiyong Xi, MSU assistant professor of
microbiology and molecular genetics. "Our work is the first to
demonstrate
Wolbachia can be stably established in a key malaria vector, the mosquito species Anopheles stephensi, which opens the door to use
Wolbachia for malaria control."
First, Xi's team successfully demonstrated how
Wolbachia can
be carried by this malaria mosquito vector and how the insects can
spread the bacteria throughout the entire mosquito population. Secondly,
researchers showed that the bacteria can prevent those mosquitoes from
transmitting malaria parasites to humans.
"We developed the mosquito line carrying a stable
Wolbachia infection," Xi said. "We then seeded them into uninfected populations and repeatedly produced a population of predominantly
Wolbachia-infected mosquitoes."
The basis for Xi's latest findings is connected to the success of his work using
Wolbachia
to halt Dengue fever. For this research, Xi focused on the mosquito
species Aedes albopictus and Aedes aegypti. This work helped launch a
global effort to develop
Wolbachia-based strategies to eliminate dengue and other diseases.
The key to the malaria research was identifying the correct species of
Wolbachia
-- wAlbB -- and then injecting it into mosquito embryos. Out of the
thousands of embryos injected by research associate Guowu Bian, one
developed into a female that carried
Wolbachia. The mosquito line derived from this female has maintained
Wolbachia
wAlbB infection with a 100 percent infection frequency through 34
generations. The number could grow higher as this is simply the last
generation the researchers have bred thus far, Xi said.
The team then introduced various ratios of
Wolbachia-infected
females into a noninfected mosquito population. In each case, the
entire population carried the bacteria in eight generations or less.
Using this promising approach to tackle malaria -- the biggest
vector-borne disease -- gives scientists and world health officials
another important tool to fight malaria.
Once
Wolbachia has been released into a mosquito population,
it is quite possible that it won't need to be reapplied, making it more
economical than other methods like pesticide or human vaccine. This
adds special value to the feasibility of this control strategy,
considering most of the malaria endemic areas are suffering from
poverty, Xi said.
Mosquitoes are
deadly efficient disease transmitters. Research conducted at Michigan
State University, however, demonstrates that they also can be part of
the solution for diseases such as malaria.